Albert T Kelley

MedTech CEO & Board Advisor | Medical Technology Sector Advisor to Corporate Finance Associates Worldwide (CFAW) | Clinical • Regulatory (510(k)) • Commercial Diligence

Role
Advisory Board Member at OncoRx Insights
Location
Sarasota, FL, US
LinkedIn followers
500 followers
Healthcare & Human ServicesView LinkedIn profile

About Albert T Kelley

MedTech Entrepreneur • Global Executive • Board Advisor • Advocate for Disruptive Medical Innovation. I’m a med-tech CEO, investor, and board advisor who now serves as a medical technology sector advisor to Corporate Finance Associates Worldwide (CFAW).I support founders, boards, and diligence teams preparing for strategic alternatives by strengthening the operating story and reducing diligence surprises—especially around regulatory pathway, clinical evidence, product/market fit, commercialization strategy, and global channel development.Over 40 years, I’ve built and scaled companies from idea to exit: 31 product launches and direct operations/JVs across North America, Europe, the Middle East, South America, and Asia-Pacific regions.Within CFAW, I serve as a Medical Technology Industry Specialist within the Healthcare Practice, supporting healthcare engagements with market/competitive landscapes, MedTech value‑driver analysis, diligence preparation, and technical/clinical/regulatory context.I combine four decades of operational experience with extensive sector knowledge to help the CFAW network’s investment banking professionals evaluate, position, and better understand medical technology opportunities.Selected operating outcomes include contributing to ZOLL Medical’s sales growth from ~US$4M to ~US$48M during my tenure and helping build Catheter Technology (Groshong®) through its acquisition, plus founding/leading OpenMed Technologies for 20 years.As a pancreatic cancer survivor, I bring a deeply personal perspective to advancing disruptive medical innovation. I recently served as President, CEO, and Board Member of Perthera AI, a precision oncology platform that uses AI and multi-omics to tailor treatment decisions for people with cancer.At CFAW, I provide medical technology operating and diligence advisory, not broker‑dealer services or investment advice.

Experience

  1. Advisory Board Member

    OncoRx Insights

    Jun 2024 — Present · Sarasota, FL, US

    Utilizing AI to bring oncologist, patients, and form together for more effective precision oncology deployment at oncology practices.

Education

  • University of Massachusetts Amherst

    Bachelor of Arts - BA, Political Science

  • Pace University - Lubin School of Business

    Master of Business Administration - MBA, Marketing

Skills

  • Sales Operations
  • Commercialization
  • Customer Service
  • New Business Development
  • Oncology
  • Fda
  • Healthcare
  • Business Development
  • Capital Equipment
  • Market Research
  • Surgery
  • Medical Imaging
  • Marketing
  • Strategic Planning
  • Cross-Functional Team Leadership
  • Marketing Strategy
  • Leadership Development
  • Mergers & Acquisitions
  • Leadership
  • Product Marketing
  • Medicine
  • Digital Imaging
  • Start-Ups
  • Hardware Diagnostics
  • Process Improvement
  • Product Development
  • Pacs
  • Sales
  • Medical Devices
  • Ehr
  • Global Marketing
  • Executive Management
  • Strategic Partnerships
  • Product Management
  • Healthcare Information Technology
  • Strategy
  • Sales Management
  • Market Development
  • Team Building
  • Management

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Albert T Kelley — Advisory Board Member at OncoRx Insights in Sarasota, FL, US | Unifers